Synergistic effects against established subcutaneous melanoma tumours were previously observed with treatment involving intra‐tumoural injection of CXCL10 or CXCL9 combined with IL‐12 treatment and was reported to cure 80% of mice. This evidence concerns the gene CXCL10 and melanoma.